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Introduction
============

Community-acquired pneumonia (CAP) is one of the main causes of hospitalization of children in the United States, with an annual estimated cost exceeding one billion dollars \[[@REF1]-[@REF2]\]. A recent prospective multicenter study conducted by the Centers for Disease Control and Prevention (CDC) reported that the annual incidence of hospitalization for CAP is 15.7 cases per 10,000 children from January 1, 2010, to June 30, 2012 \[[@REF3]\].

Viruses are by far the most common cause of CAP while bacteria account for only 15% of cases \[[@REF3]\]. After the introduction of the vaccines against Streptococcus pneumoniae and Haemophilus influenza type B, the rates of CAP secondary to these invasive bacterial infections have decreased from 7.7% to 4% \[[@REF4]-[@REF6]\].

National guidelines for the management of infants and children with CAP, established in 2011 by the Infectious Diseases Society of America (IDSA), recommend \"only obtaining blood culture in children with moderate and severe CAP\" \[[@REF7]\]. This statement, as mentioned in the guideline, fails to accurately define what would be considered \"moderate to severe CAP.\" Past studies have reported a wide range in the prevalence of bacteremia in CAP (0.8%-17.4%) \[[@REF8]-[@REF13]\].

A drawback of routine cultures is a high proportion of blood culture contamination, ranging from 0.7% to 8.1% \[[@REF14]-[@REF21]\]. This results in prolonged hospital stay with subsequent increased cost \[[@REF18]-[@REF19]\]. Blood culture results may influence the management in only 2.2% of the cases \[[@REF22]-[@REF24]\].

A meta-analysis published in 2015 on the role of blood culture in pediatric CAP found that studies focusing on patients with severe CAP had a higher prevalence of bacteremia when compared to studies that included non-severe CAP. Validated clinical prediction rules or stratification criteria to define or categorize the severity of pediatric CAP are not available \[[@REF14]\]. In adults, a six-point scoring system based on the presence of confusion, uremia, respiratory rate, blood pressure, and age ≥ 65 years (CURB-65 (confusion, urea, respiratory rate, blood pressure, and 65 years of age or older) score) is widely adopted to define severe pneumonia \[[@REF25]-[@REF27]\]. Few studies have attempted to describe the correlation of clinical or radiological parameters like toxic appearance or presence of effusion with bacteremia secondary to CAP in children \[[@REF28]\].

The main study objective was to identify the prevalence of bacteremia in pediatric patients hospitalized with CAP in two tertiary-level hospitals. Secondary objectives included: (1) to determine the prevalence of false-positive blood cultures, (2) to identify the microbiology and susceptibility patterns of true positive blood cultures, (3) to identify the clinical and laboratory variables associated with bacteremia in patients hospitalized with CAP, and (4) to determine the impact of blood culture results on antimicrobial therapy and length of hospital stay.

Materials and methods
=====================

This is a medical record review of all patients admitted to New York City (NYC) Health and Hospitals/Kings County Hospital (KCH) and State University of New York, Downstate Medical Center (DMC) with a diagnosis of community-acquired pneumonia between January 1, 2013, and December 31, 2017. Both centers are tertiary-level hospitals located in Brooklyn, New York. The Institutional Review Board at KCH and DMC approved the study protocol.

We included children and adolescents aged two months to 18 years of age. Subjects were identified according to International Classification of Diseases, Ninth Revision (ICD-9) (480-488.1, 510-511, 513, Jan 1 2013-Sept 30 2015) and ICD-10 (J10-J18.9, Oct 1 2015- Dec 31 2017) codes for pneumonia. We excluded children and adolescents with a diagnosis of hospital-acquired pneumonia, defined as pneumonia diagnosed more than 48 hours from admission or less than two weeks after hospital discharge, as well as children living in chronic care facilities.

Charts were manually reviewed to obtain demographic, clinical, and laboratory data, which included relevant past medical history (previous history of pneumonia, chronic lung disease, asthma, immunodeficiency, sickle cell disease, cerebral palsy), recent use of antibiotics (defined as any patient who self-reported antibiotics use five days before hospitalization ), vaccination status (including influenza vaccine in the last season ), vital signs, general appearance, respiratory examination findings, relevant laboratory results (white blood cell count, neutrophil count, C-reactive protein), imaging studies (chest X-ray, ultrasound, tomography), blood culture (obtained in the first 48 hours upon admission), as well as results of other microbial testing, including nasopharyngeal aspirate and pleural fluid analysis (cell count, pH, protein, glucose, lactate dehydrogenase (LDH), culture). Complications encountered during the hospital course included admission or transfer to the pediatric intensive care unit, supplemental oxygen requirement, and ventilatory support. Length of stay was also recorded.

The distinction between true-positive vs. contaminated blood cultures was determined by the primary team taking care of the patient and later reviewed by two of the authors (AY and EFM).

Results
=======

We collected data from 464 children. The median age was three years (IQR 2-6) and 51.9% were female. A total of 162 (34.9%) had no significant past medical history and 446 (96%) were up-to-date on their immunizations, as shown in Table [1](#TAB1){ref-type="table"}. Table [1](#TAB1){ref-type="table"} outlines the demographic and clinical characteristics of our population.

###### Demographic and clinical characteristics of children admitted with CAP

CAP: community-acquired pneumonia; SMA-1: spinal muscular atrophy; PMH: past medical history; PCV: Pneumococcal vaccine; HiB: Haemophilus influenzae type b; ER: emergency room; NIV: noninvasive ventilation

  ------------------------------------------ --------------------------------
  Demographic and Clinical Characteristics   
  Gender                                     Male: 222
  Female: 241                                
  Medical history                            Asthma: 209
  Sickle cell disease: 40                    
  Cerebral palsy: 15                         
  Immunodeficiency: 3                        
  Seizures disorder: 6                       
  Prematurity: 6                             
  SMA-1: 2                                   
  Others: 16                                 
  No significant PMH: 162                    
  Vaccination                                PCV: 446
  HiB: 446                                   
  Influenza: 285                             
  Received antibiotics prior to admission    Total: 64
  Amoxicillin: 41                            
  Macrolides: 11                             
  Cephalosporins: 7                          
  Penicillin: 4                              
  Bacterium: 1                               
  Clinical examination                       Fever: 270
  Crackles: 142                              
  Wheezes: 175                               
  Retractions: 208                           
  Decreased air entry: 140                   
  PICU admission                             Directly admitted from ER: 108
  Transferred from the regular ward: 16      
  Respiratory support                        Oxygen by nasal cannula: 134
  NIV 2: 60                                  
  Intubation: 8                              
  Radiographic findings                      Focal consolidation: 311
  Perihilar opacity: 76                      
  Atelectasis effusion /necrotizing: 18      
  Normal: 19                                 
  No chest X-ray: 40                         
  WBC 10^3^/µL; CRP mg/L                     \< 15 000: 361
  \>15 000: 103                              
  \< 5: 16                                   
                                             5-10: 6
  10-50: 33                                  
  50-100: 18                                 
                                             100-200: 24
  200-300: 9                                 
  \>300: 3                                   
  First-line Antibiotic                      Ampicillin: 178
  Cephalosporins: 199                        
  No antibiotics: 22                         
  ------------------------------------------ --------------------------------

A total of 380 blood cultures were obtained, including 23 patients who had repeated blood cultures. Fifteen (3.9%) cultures were positive for bacterial growth; five (1.3%) were considered true positives while the other 10 (2.6%) were treated as contaminants. The prevalence of bacteremia was 1.3% in those with blood cultures and 1.0% in all patients admitted with CAP (Table [2](#TAB2){ref-type="table"}). Except for one patient who had human immunodeficiency virus (HIV) with low cluster of differentiation 4 (CD4) count, none of our bacteremic patients had immunodeficiency, indwelling central line, or sickle cell disease; however, two of them had a history of asthma and prematurity. Out of the five cases of bacteremia, three were caused by S. pneumoniae, one caused by methicillin-resistant, Staphylococcus aureus, and one by Enterococcus avium.

###### Demographic, clinical, laboratory, and radiological characteristics of patients with bacteremia

HIV: human immunodeficiency syndrome; AIDS: acquired immunodeficiency syndrome; CD4: cluster of differentiation 4; HAART: highly active antiretroviral therapy; MRSA: methicillin-resistant Staphylococcus aureus; ARDS: acute respiratory distress syndrome; NICU: neonatal intensive care unit; CLD: chronic liver disease; CPAP: continuous positive airway pressure; BIPAP: bilevel positive airway pressure

  ---- ---------- -------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- ------- -------------------------------------------- -------------- ---------- --------------------------------------------- --------------------------------------------------------------------------------------------------------------------------
  No   Age        PMH                                                                                                Cultures                                                                                 Hospital course                                                                                 Toxic   ICU                                          WBC 10^3^/uL   CRP mg/L   CXR                                           Antibiotics
  1    18 years   Congenital HIV AIDS (viral load 6,270,000, CD4 2.59, noncompliant with HAART 1 and azithromycin)   Blood culture: MRSA. Tracheal aspirate Culture: MRSA. Sputum Culture: candida albicans   ARDS+septic shock 2                                                                             Yes     Direct admission                             3.24           N/A        Cavitary lesion                               Initial:-vancomycin, piperacillin/ tazobactam, and azithromycin. Final: -the patient was transferred to another hospital
  2    5 months   Preterm 34 weeks NICU for 1 month. No Hx of CLD 3.                                                 Blood culture: Enterococcus avium sensitive to Ampicillin.                               Needed CPAP 4, positive blood culture treated as true infection                                 Yes     Direct admission                             10.2           104        Mild pleural effusion. Did not need tapping   Initial­:- vancomycin, ceftriaxone, azithromycin. Final: - ampicillin.
  3    6 years    Moderate persistent asthma                                                                         Blood culture: Streptococcus pneumoniae                                                  Improvement In the first 24 hours. -But delay in discharge waiting for second culture results   No      No                                           15.3           N/A        Focal consolidation                           Initial: - ampicillin. Final: - ampicillin
  4    8 years    None                                                                                               Blood culture: Streptococcus pneumoniae                                                  Improvement in the first 24 hours. But unnecessary antibiotic upgrade and delay in discharge    No      No                                           30             N/A        Focal consolidation                           Initial: - ampicillin and azithromycin; later changed to ceftriaxone based on culture results. Final: - amoxicillin
  5    3 years    None                                                                                               Blood culture: Streptococcus Pneumoniae. Pleural fluid culture: no growth.               Needed BIPAP 5, and right-side decortication                                                    No      Transferred on the second day of admission   17             321        Large pleural effusion                        Initial ampicillin; later changed to ceftriaxone and vancomycin. Final: - amoxicillin
  ---- ---------- -------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- ------- -------------------------------------------- -------------- ---------- --------------------------------------------- --------------------------------------------------------------------------------------------------------------------------

Three out of five bacteremic patients were admitted to the pediatric intensive care unit (PICU). Two were admitted directly from the emergency department (ED) to the PICU and were treated aggressively with broad-spectrum antibiotics. One patient was initially treated with ampicillin in the inpatient unit but deteriorated clinically and was transferred to the PICU, where antibiotic treatment was advanced to ceftriaxone and vancomycin.

Two patients who were admitted to the inpatient unit were started on ampicillin and continued to show improvement on the same antibiotic. We found a significant association between PICU admission (OR 5.6 and 95% CI (1.0-31), p\<0.03) and ill appearance on presentation (OR 12.8 and 95% CI (1.3-125), p\<0.01) with a true-positive blood culture.

Ten out of 15 positive cultures (67 %) were contaminated: three of the contaminant cultures grew Streptococcus viridans, two grew Staphylococcus hominis, one culture grew both Acinetobacter baumannii and Corynebacterium striatum while the remaining grew Staphylococcus haemolyticus, Staphylococcus simulans, and Rothia spp. Fifty percent of the false-positive cultures were repeated. (Table [3](#TAB3){ref-type="table"}).

###### Demographic, clinical, laboratory, and radiological characteristics of patients with false-positive (contaminated) blood cultures

WBC: white blood cell; CXR: chest X-ray; CRP: C-reactive protein; ED: emergency department

  ----- ----------- ------------- ------------------------------------------------------------- ----- ------------------ ------ ---------- ------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  No.   Age         Vaccination   PMH                                                           ICU   WBC 10^3^/^27^ul   CXR    CRP mg/L   Hospital course                                                                                                                                   Cultures                                                                                                                    Antibiotics
  1     20 months   Yes           None                                                          No    22.5               N      No         Hospital stay: 21 hours.                                                                                                                          Blood culture: Staph simulans                                                                                               Initial: Amoxicillin for 1 day. Final: Amoxicillin 10 days as an outpatient
  2     19 months   No            None                                                          No    11.8               N      No         Hospital stay 50 hours                                                                                                                            Blood culture: Staph Hominis                                                                                                Initial: Ceftriaxone for 1 day. Final: Amoxicillin for 10 days as an outpatient
  3     3 years     Yes           None                                                          No    8.7                N      No         Hospital stay 24 hours                                                                                                                            Blood culture: Strep Viridans                                                                                               Ampicillin one dose in the ED
  4     6 years     Yes           Mild persistent asthma                                        No    17.1               N      No         Hospital stay 1 day and 21 hours                                                                                                                  Blood culture: Staph Hominis                                                                                                Initial: Ampicillin one dose in the ED. Final: Amoxicillin for 10 days as an outpatient
  5     4 months    No            None                                                          No    27.1               37.3   No         Hospital stay: 2 days,15 hours Inpatient team impression that blood culture is contaminant                                                        Blood culture: Strep Viridans Urine culture: Pseudomonas.                                                                   Initial: ceftriaxone for 2 days. Final: cephalexin for 10 Days as an outpatient.
  6     4 years     Yes           None                                                          No    9.9                N      No         Hospital stay 1 day, 5 hours                                                                                                                      Blood culture: Rothia Dentocariosa                                                                                          Ceftriaxone one dose in the ED
  7     2 years     Yes           None                                                          Yes   7                  N      No         PICU for 13 hours, inpatient team impression it is a contaminant, but continued antibiotics. Normal Echo. Total hospital stay: 3 days,13 hours.   Blood culture: Strep viridans                                                                                               Initial: Ceftriaxone for 1 day then ampicillin for 2 days. Final: amoxicillin for 7 as an outpatient
  8     2 years     No            Williams syndrome. Mild persistent asthma. Has tracheostomy   Yes   15                 7.7    No         treated for the Serratia marcescens infection. Blood culture considered a contaminant. Total hospital stay: 4 days,21 hours                       Blood culture: Acinetobacter baumanni+ Corynebacterium Striatum. Tracheal aspirate culture: Serratia marcescens RVP1: RSV   Ceftriaxone for 3 days. Then cefixime for 2 days
  9     16 years    No            Cerebral palsy G-tube. Scoliosis                              Yes   11.2               N      No         Treated as Aspiration pneumonia. 1 day in PICU, NIV not needed. Total hospital stay: 4 days, 1 hour.                                              Blood culture staph capitis                                                                                                 Ceftriaxone + Ampicillin/Sulbactam for 1 day. Then Amoxicillin+ clavulanic acid for 4 days
  10    7 years     Yes           Intermittent asthma                                           No    5.7                N      No         Hospital stay: 7 hours.                                                                                                                           Blood culture: Staph haemolyticus                                                                                           Ampicillin one dose in the ED
  ----- ----------- ------------- ------------------------------------------------------------- ----- ------------------ ------ ---------- ------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------

Finally, in regard to the radiological and laboratory investigations. Of 19 (4%) patients with evidence of effusion or necrotizing pneumonia on chest radiographs, three out of the 19 patients had positive blood cultures; and out of these three, only one patient underwent pleural fluid tapping. Two additional patients who underwent pleural tapping had negative blood cultures, and none of these three patients who undergone tapping had positive pleural fluid cultures. The radiographic evidence of effusion or necrotizing pneumonia was associated with bacteremia (P\<0.11) while the binary logistics regression analysis showed that significantly elevated CRP (\> 300 mg/L) was associated with a true-positive blood culture (p\<0.01).

Discussion
==========

Bacteremia is an unusual complication of CAP in hospitalized children. Our study suggests that approximately 1% of admitted children with CAP are bacteremic. Penicillin-susceptible S. pneumoniae was the most common isolated organism (60%), which is consistent with recently published studies \[[@REF15]\]. Patients with bacteremia mostly had co-morbid conditions, were ill-appearing, or were admitted to the PICU. Our findings are consistent with current IDSA guidelines, which suggest that only children with moderate to severe CAP will benefit from obtaining a blood culture on admission.

Unlike some reports, we did not find a correlation between the radiological findings of effusion or necrotizing pneumonia and a truly positive blood culture. Heine et al. found that five out of 155 children who were admitted with pneumonia to the Children\'s Hospital at the Medical University of South Carolina or discharged from the ED were bacteremic; all five cases had parapneumonic effusions \[[@REF28]\]. Heine et al. found that five out of 155 children who were admitted to the Children\'s Hospital at the Medical University of South Carolina with pneumonia were bacteremic and all of them had parapneumonic effusions. Similarly, Kwon et al. found a low prevalence of bacteremia in 2705 previously healthy children and adolescents. Of 2705, only three children (0.11%) had true-positive results, and all of them had pneumonia complicated with pleural effusion \[[@REF29]\]. Another study by Myers et al. reported that children who required pleural drainage procedure or had a distant site infection had higher rates of bacteremia - 21% and 75%, respectively \[[@REF11]\].

Toxic appearance and admission or transfer to the PICU were associated with bacteremia. This is consistent with prior reports from Heine et al., where four out of five children with CAP complicated by bacteremia required ICU care.

The impact in the management of the blood culture results was limited in our study. Two patients were admitted directly to the ICU while a third one was transferred from the inpatient unit after clinical deterioration. The results from the blood culture allowed for accurate diagnosis in all of them and appropriate antibiotic de-escalation at least in two of the patients.

For the two other patients admitted to the inpatient unit, these results led to a therapeutic dilemma with subsequent prolongation of hospital stay for both of them and unnecessary broadening of antibiotics for one of them, even though the reported organism was penicillin-susceptible S. pneumoniae.

The prevalence of blood culture contaminants in this study was 2.6%, which is similar to prior reports \[[@REF28]\]. Furthermore, a positive blood culture was twice more likely to be a contaminant than a true pathogen. Despite the high likelihood of reported growth in blood culture to be a contaminant, determining the possibility of true bacteremia is still challenging for physicians and impacts negatively on patient care. In this study, five of the 10 patients with false-positive cultures had repeated cultures, even though the treating physician\'s impression was in favor of a contaminant organism.

This study has several limitations. Our research is a retrospective chart review that is more prone to chart abstraction biases, especially personal data such as ill appearance. This study was done in our two urban academic medical centers and its results may not be generalizable to other institutions. Finally, we do not have data on whether children discharged from our two facilities may have been readmitted to other hospitals.

Conclusions
===========

The rate of positive blood cultures in children admitted with CAP is low, and its impact on clinical management is limited. Children that were ill-appearing, admitted to the intensive care unit, or with significantly elevated CRP levels were more likely to have bacteremia secondary to CAP. The current recommendation of obtaining a blood culture for children with moderate to severe CAP, although correct, needs to be clarified. Further studies are needed to better risk-stratify children with CAP, thus providing a targeted approach for obtaining blood cultures, standardizing management, and potentially reducing the cost and length of hospital stay.
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